The product MycoAir II is based on the principles of traditional Chinese medicine. It combines the effects of medicinal mushrooms and Chinese medicinal plants. The author of the recipe isMUDr. Lucký, our leading specialist in traditional Chinese medicine.
MycoAir II contains a unique combination of immunomodulatory action of two selected mushrooms and five Chinese medicinal plants. The product as a whole has a preventive effect. The combination of astragalus, atractylis and ledebouriella supports the immune system. These three herbs have been coexisting for centuries and they form the herb combination called Nefrit Windbreak. Old masters used this name to honour the excellent effect of the herbs on natural defences of the organism.
Package contents: 180 tablets at 350mg
Composition of 1 capsule:
Cordyceps CS-4 or caterpillar fungus (Cordyceps sinensis) – 50mg
Reishior Ganoderma Lucidum (lingzhi mushroom) – 99mg
Huang Qi or Astragalus (Radix astragali) – 66mg
Bai Zhu or atractylis (Rhizoma atractylodis) – 34mg
Fang Feng or ledebouriella (Radix ledebouriellae) – 34mg
Ku Shen or shrubby sophora (Radix sophorae) – 34mg
Wu Wei Zi or magnolia berry (Fructus schisandrae) – 16mg
excipients: microcrystalline cellulose, magnesium stearate, colloidal silicon dioxide
Most of our raw mushroom material comes from China. Ecology isn’t often a priority for contemporary China. Therefore, it’s difficult, but at the same time necessary to seek absolutely pure nature untouched by industry for cultivation of medicinal mushrooms. MycoMedica mainly uses mushrooms grown in in the Fujian, Anhui and Jiangxi provinces, where there are areas virtually untouched by civilisation. Pesticides, heavy metals, microorganisms, moulds, radioactivity are a danger, which raw mushroom material must be protected against unconditionally.
All the raw mushroom material we use to produce our mushroom products is tested before processing in Agrolab, an independent German laboratory for more than 500 types of known heavy metals, pesticides and microorganisms that are harmful to humans. We are able to present these tests on request.
Classic tests conducted by the German lab. Agrolab have now been expanded with testing forpolycyclic aromatic hydrocarbons (PAHs), which have carcinogenic effects, which can affect fetal development and are also linked to cardiovascular diseases. See here.
The final production of our products takes place under the strictest hygienic conditions in the Czech Republic. For our production, we use the standards ISO 9001/2009, certified HACCP and the system of quality IFS.
We also offer free advisory services for our products.
When your order is over 2,000 CZ, shipping is free.
For larger orders, we have discounts:
We train experts in mycotherapy, who can use our mushrooms effectively in their practice. We also hold international seminars on medicinal mushrooms, these are attended by leading experts on this issue.
If we want to use as many active substances as possible from mushrooms, we must process them allowing them to disrupt the chitinous envelope of the mushroom cell. Humans don’t have the necessary enzymes to digest chitin, so they’re unable to release active substances from the mushroom cell wall during digestion and instead they excrete them from their organism.
It’s possible to produce a decoction from dried mushrooms. However, this traditional method requires a large number of mushrooms to achieve therapeutic effects.
b) mushroom powder or biomass
Dried mushrooms are ground to a very fine powder. This partially disturbs the chitin envelope and the body is then able to extract active substances from the mushroom.
We can break the chitin barrier using gentle extraction with hot water and extract the maximum amount of active substances from the mushroom. In the case of most kinds of mushrooms, it’s also necessary to perform condensation using ethanol at the end of the extraction process (the so-calleddouble extraction ), as some active substances are water insoluble.
Extraction is the most optimal method for processing mushrooms for medical purposes. This is why the overwhelming majority of medical studies are conducted with extracts and not with mushroom powder.
The main, although not the only active substances of medicinal mushrooms are polysaccharides (mainly β-(1, 3)-D-glucans). While dried powder contains about 0.5‒3% polysaccharides, our extracts contain 30%.
Another good argument for the use of MycoMedica mushrooms is that a great many doctors and Chinese medicine practitioners are working with our products and they’ve had only the best experience with them. Seehere.
We also use MycoMedica products in our doctor’s office, so we have everyday feedback on their beneficial effects.
Some companies use entirely common raw mushroom material for processing, in order to achieve a higher percentage of polysaccharide content. Common labs won’t recognise the difference. However, this raw material has minimal therapeutic effects. If indeed, it has any at all. Together with our German colleagues, we have been testing all raw mushroom material, so that it contains only high-quality mushroom polysacharides..
Some Chinese companies, in order to achieve microbiological purity of extracts, expose mushrooms to the effects of radioactive radiation, which destroys microorganisms. We emphasise that MycoMedica products aren’t exposed to radiation in in any phase of production.
Some Chinese manufacturers don’t respect traditional manufacturing practices. For example, mushroom drying must be done slowly and in sunshine. This is why it’s so important for us to cooperate only with proven growers and processors of raw mushroom material. We don’t use any unverified raw material in our products.
We don’t take our motto QUALITY - SAFETY - EFFICIENCY lightly. Thanks to this, we have gradually become the most important East European producer of products from medicinal mushrooms.